Cold Iron Truth

Melanoma in situ: It’s hard to know what you don’t know


 


Many dermatologists, as well as teaching programs, use PAs to perform skin cancer screenings, sometimes unsupervised, which makes diagnostic accuracy critical. The issues at hand are the safety of patients and the accuracy of diagnosis as well as the costs to the health care system. A team effort, which includes direct supervision, is needed to ensure those issues are addressed.

Dr. Coldiron is in private practice but maintains a clinical assistant professorship at the University of Cincinnati. He cares for patients, teaches medical students and residents, and has several active clinical research projects. Dr. Coldiron is the author of more than 80 scientific letters, papers, and several book chapters, and he speaks frequently on a variety of topics. He is a past president of the American Academy of Dermatology. Write to him at dermnews@mdedge.com.

Pages

Recommended Reading

MDedge Daily News: Do HPV vaccines really cut cancer risk?
MDedge Dermatology
New Medicare cards
MDedge Dermatology
White House pushes transparency in drug price plan
MDedge Dermatology
Patients who record office visits
MDedge Dermatology
Diet
MDedge Dermatology
Two more and counting: Suicide in medical trainees
MDedge Dermatology
FDA’s Gottlieb floats ideas on Medicare drug coverage
MDedge Dermatology
No-shows
MDedge Dermatology
Guidelines-based intervention improves pediatrician management of acne
MDedge Dermatology
Specialty practices hire more physician assistants and nurse practitioners
MDedge Dermatology